# Antibacterial Activity of Palmarosa (Cymbopogon martini (Roxb.) Will.Watson) Essential Oil and Geraniol Against Clinical Isolates from Respiratory, Skin, and Soft Tissue Infections

**Authors:** Pilar Cebollada, Elena Alvarado, Cristina Seral, Víctor López

PMC · DOI: 10.3390/pharmaceutics18010039 · 2025-12-27

## TL;DR

This study tests the antibacterial effects of palmarosa essential oil and its main component geraniol against bacteria causing skin and respiratory infections.

## Contribution

The novelty is evaluating palmarosa oil and geraniol against clinical isolates from skin and respiratory infections, including their effects on mammalian cells.

## Key findings

- Palmarosa oil showed lower MIC values than geraniol against some Gram-positive and Gram-negative bacteria.
- The oil had a weaker impact on HepG2 cells compared to geraniol.
- Activity was observed against Streptococcus and Staphylococcus species, as well as Escherichia coli and Moraxella catarrhalis.

## Abstract

Background/Objectives: Essential oils are liquid natural volatile mixture of compounds with several bioactive properties, which make them useful in a wide range of pharmaceutical applications. The aim of this work is to explore the antimicrobial impact of Cymbopogon martini essential oil against human clinical bacterial isolates from the skin and respiratory tract while also assessing its impact on mammalian cells. Geraniol, its main component according to GC-MS analysis, was evaluated under the same conditions. Methods: The composition of the essential oil was provided by the supplier. To elucidate the antimicrobial activity, the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) were determined. The impact on mammalian hepatic cells was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: The essential oil showed activity against Gram-positive bacteria from the Streptococcus and Staphylococcus genera, with MIC values ranging from 125 to 250 µg mL−1 for Streptococcus agalactiae, Streptococcus anginosus, Streptococcus disgalactiae， and Streptococcus pyogenes. It also displayed activity against some of the tested Gram-negative bacteria, namely, Escherichia coli (MIC 350 µg mL−1), Moraxella catarrhalis (MIC 250 µg mL−1), and Morganella morganii (MIC 350 µg mL−1). In most cases, the essential oil showed lower MIC values than geraniol. Additionally, palmarosa oil had a weaker impact than geraniol in HepG2 cells. Conclusions: Both the essential oil and the pure compound exhibited activity against clinical isolates obtained from skin and respiratory tract samples.

## Linked entities

- **Chemicals:** geraniol (PubChem CID 637566)
- **Species:** Streptococcus agalactiae (taxon 1311), Streptococcus anginosus (taxon 1328), Streptococcus pyogenes (taxon 1314), Escherichia coli (taxon 562), Moraxella catarrhalis (taxon 480), Morganella morganii (taxon 582)

## Full-text entities

- **Diseases:** Respiratory, Skin, and Soft Tissue Infections (MESH:D018461)
- **Chemicals:** Geraniol (MESH:C007836), Cymbopogon martini essential oil (-), MTT (MESH:C070243), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), Essential Oil (MESH:D009822)
- **Species:** Streptococcus agalactiae (species) [taxon 1311], Streptococcus anginosus (species) [taxon 1328], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Morganella morganii (species) [taxon 582], Streptococcus pyogenes (species) [taxon 1314], Homo sapiens (human, species) [taxon 9606], Moraxella catarrhalis (species) [taxon 480], Cymbopogon martini (species) [taxon 79837], Escherichia coli (E. coli, species) [taxon 562], Staphylococcus (genus) [taxon 1279]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12844656/full.md

---
Source: https://tomesphere.com/paper/PMC12844656